Position in PFE
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,767,014
-$255,504 QoQ
Shares Held
73,381
+1.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,014
of 2,820 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PROFUND ADVISORS LLC holds $71,666,047 across 14 Drug Manufacturers - General names. PFE ranks #8 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
51,320 | $18,583,998 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
110,868 | $14,007,063 | |
| 3 | LLY |
ELI LILLY & Co
|
9,538 | $11,440,164 | |
| 4 | JNJ |
Johnson & Johnson
|
32,688 | $8,301,771 | |
| 5 | ABBV |
AbbVie Inc.
|
26,168 | $6,584,915 | |
| 6 | MRK |
Merck & Co., Inc.
|
33,549 | $4,311,046 | |
| 7 | BIIB |
Biogen Inc.
|
8,560 | $1,849,473 | |
| 8 | PFE |
Pfizer Inc
This page
|
73,381 | $1,767,014 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,767,014 | 73,381 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $2,022,518 | 72,027 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $2,544,132 | 102,174 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $2,175,711 | 85,389 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,118,018 | 87,377 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $2,341,086 | 92,387 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $2,533,137 | 95,482 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,166,470 | 109,415 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,869,796 | 102,566 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $3,017,479 | 108,738 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $3,303,364 | 114,740 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,477,907 | 104,851 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,867,906 | 105,450 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $4,160,743 | 101,979 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $5,261,630 | 102,686 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $6,705,651 | 153,237 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $8,536,809 | 162,823 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $9,327,245 | 180,167 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $11,963,707 | 202,603 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $8,092,073 | 188,144 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $7,661,105 | 195,636 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $6,985,868 | 192,820 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $7,469,264 | 202,914 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $5,021,802 | 136,834 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $5,524,409 | 168,942 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $4,176,445 | 127,955 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||